Klaartje van Engelen

Amsterdam University Medical Centers — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

29h-index3.1kcitations79works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

BRCA gene mutations in cancer(28), Congenital heart defects research(17), Congenital Heart Disease Studies(15), Ovarian cancer diagnosis and treatment(13), Nutrition, Genetics, and Disease(9)

Publications70 total

Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density
Osteoporosis International·2025· 1 citedOpen Access
Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer
British Journal of Urology·2025Open Access
No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO)
Maturitas·2025· 2 citedOpen Access
High-impact complications after breast cancer surgery in the Dutch national quality registry: evaluating case-mix adjustment for hospital comparisons
BJS Open·2024· 4 citedOpen Access
Coronary Artery Calcium Scores After Prophylactic Premenopausal Bilateral Salpingo-Oophorectomy
JACC CardioOncology·2024· 8 citedOpen Access
P113 Prevalence of pathogenic germline variants in 779 patients with metastatic prostate cancer and 16,823 controls
European Urology Open Science·2024Open Access
Cohort profile: a nationwide study in Dutch <i>CHEK2</i> c.1100delC families using the infrastructure of the HEreditary Breast and Ovarian cancer study Netherlands – Hebon-CHEK2
BMJ Open·2024· 2 citedOpen Access
Urinary incontinence more than 15 years after premenopausal risk‐reducing salpingo‐oophorectomy: a multicentre cross‐sectional study
BJOG An International Journal of Obstetrics & Gynaecology·2023· 2 citedOpen Access
Coronary Artery Calcification in women with a premenopausal RRSO compared to women with a postmenopausal RRSO
Maturitas·2023
High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of <i>BRCA1/2</i> Pathogenic Variants: Prevalence and Clinical Factors
Journal of Clinical Oncology·2023· 12 citedOpen Access
Long‐term effects of premenopausal risk‐reducing salpingo‐oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross‐sectional study
BJOG An International Journal of Obstetrics & Gynaecology·2023· 9 citedOpen Access
Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy
American Journal of Obstetrics and Gynecology·2022· 6 citedOpen Access
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
Communications Biology·2022· 12 citedOpen Access
Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study
PLoS ONE·2022· 6 citedOpen Access
Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases
Journal of Medical Genetics·2022· 36 citedOpen Access
Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study
The Breast·2021· 34 citedOpen Access
OP018/#414 Progression free survival and overall survival after BRCA1/2-ASSOCIATED epithelial ovarian cancer: a matched cohort study
2021Open Access
Effect of a health literacy training program for surgical oncologists and specialized nurses on disparities in referral to breast cancer genetic testing
The Breast·2021· 13 citedOpen Access
Endometrial Cancer Risk in Women With Germline <i>BRCA1</i> or <i>BRCA2</i> Mutations: Multicenter Cohort Study
JNCI Journal of the National Cancer Institute·2021· 88 citedOpen Access
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
American Journal of Obstetrics and Gynecology·2021· 56 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Barbara J.M. Mulder(16), Alex V. Postma(15), Margreet G.E.M. Ausems(15), Christi J. van Asperen(12), Maartje J. Hooning(12), Marian J.E. Mourits(12), Marieke J.H. Baars(11), E. Gómez(11), Bernadette A. M. Heemskerk‐Gerritsen(9), Flora E. van Leeuwen(9), Matti A. Rookus(8), Marijke R. Wevers(8), Bernard Keavney(7), Irma van de Beek(7), Lieke P. V. Berger(7), Antoon F.M. Moorman(6), Joanne A. de Hullu(6), Marc van Beurden(6), Helena C. van Doorn(6), B.F.M. Slangen(6)